4 hours Cartesian Therapeutics, Inc. (NASDAQ:RNAC) Given Average Recommendation of “Moderate Buy” by Brokerages MarketBeat
Cartesian Therapeutics, Inc. (NASDAQ:RNAC – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight research firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the st…